Emergent Biosolutions (EBS) Files $180M Mixed Shelf; 3M Common for Shareholders

May 3, 2012 5:15 PM EDT Send to a Friend
Emergent Biosolutions, Inc. (NYSE: EBS) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $180 million of Common Stock, Preferred Stock, Debt Securities, Warrants, or any combination thereof.

Emergent also filed to sell up to 3 million of its Common on behalf of selling shareholders. Emergent will not receive proceeds from the secondary offering.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Equity Offerings

Add Your Comment